Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study

PURPOSE: Currently, there are no accurate markers for predicting potentially lethal prostate cancer (PC) before biopsy. This study aimed to develop urine tests to predict clinically significant PC (sPC) in men at risk. METHODS: Urine samples from 928 men, namely, 660 PC patients and 268 benign subje...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsiang-Po, Chen, Chung-Hsin, Chang, Kai-Hsiung, Lee, Ming-Shyue, Lee, Cheng-Fan, Chao, Yen-Hsiang, Lu, Shih-Yu, Wu, Tzu-Fan, Liang, Sung-Tzu, Lin, Chih-Yu, Lin, Yuan Chi, Liu, Shih-Ping, Lu, Yu-Chuan, Shun, Chia-Tung, Huang, William J., Lin, Tzu-Ping, Ku, Ming-Hsuan, Chung, Hsiao-Jen, Chang, Yen-Hwa, Liao, Chun-Hou, Yu, Chih-Chin, Chung, Shiu-Dong, Tsai, Yao-Chou, Wu, Chia-Chang, Chen, Kuan-Chou, Ho, Chen-Hsun, Hsiao, Pei-Wen, Pu, Yeong-Shiau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566053/
https://www.ncbi.nlm.nih.gov/pubmed/37821919
http://dx.doi.org/10.1186/s12967-023-04424-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566053/
https://www.ncbi.nlm.nih.gov/pubmed/37821919
http://dx.doi.org/10.1186/s12967-023-04424-9

Ejemplares similares